Objective
To investigate the association of non-cavity distorting uterine fibroids and pregnancy outcomes following ovarian stimulation-intrauterine insemination (OS-IUI) in couples with unexplained infertility.
Design
Secondary analysis from a prospective, randomized, multicenter clinical trial investigating fertility outcomes following OS-IUI.
Setting
Reproductive Medicine Network clinical sites
Patients
Nine-hundred couples with unexplained infertility who participated in the Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation (AMIGOS) clinical trial.
Intervention
Participants were randomized to one of three arms (clomiphene citrate, letrozole, or gonadotropins) and treatment was continued for up to four cycles or until pregnancy was achieved.
Main outcomes measures
Conception (serum hCG increase), clinical pregnancy (fetal cardiac activity), and live birth rates.
Results
102/900(11.3%) participants had at least one documented fibroid and a normal uterine cavity. Women with fibroids were older, more likely to be African American, had a greater uterine volume, lower serum anti-Mullerian hormone levels, and fewer antral follicles than women without fibroids. In conception cycles, clinical pregnancy rates were significantly lower in participants with fibroids than those without uterine fibroids. Pregnancy loss prior to 12-weeks was more likely in African American women with fibroids compared to non-African American women with fibroids. There was no difference in conception and live birth rates in subjects with and without fibroids respectively.
Conclusions
No differences were observed in conception and live birth rates in women with non-cavity distorting fibroids and those without fibroids. These findings provide reassurance that pregnancy success is not impacted in couples with non-cavity distorting fibroids undergoing OS-IUI for unexplained infertility.